• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ TORIC SINGLEPIECE IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ TORIC SINGLEPIECE IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number SN6AT6
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Pain (1994); Blurred Vision (2137)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
The product was not returned.Complaint history and product history records could not be reviewed because the literature report did not provide a lot number or any identification traceable to the manufacturing documentation.A malfunction has not been indicated against the lens.The file has been opened from a literature report: pseudouveitis and iris atrophy in pigment dispersion syndrome after sulcus implantation of a one-piece iol with square edge haptics.The clinical findings were pigment dispersion syndrome, secondary to the iol in the sulcus rubbing against the iris.The symptoms resolved after 1.5 years.The lens remaining implanted.The directions for use state the lens is intended for placement in the capsular bag.The safety and effectiveness of a posterior chamber lens, if placed in the anterior chamber, has not been established.The placement of the iol in the sulcus may be a potential contributory factor.The manufacturer internal reference number is: (b)(4).
 
Event Description
In a literature report entitled "pseudouveitis and iris atrophy in pigment dispersion syndrome after sulcus implantation of a one-piece iol with square edge haptics", the author discussed a patient with pigment dispersion syndrome following intraocular lens (iol) implantation in the ciliary sulcus.The patient was mistakenly treated for non-granulomatous anterior uveitis.She developed irvine-gass syndrome in the right eye post-operatively with episodes of ocular pain, blurred vision, and headaches, starting a few months after the procedure.She was treated with a topical steroid and hypotensive drugs.Iris atrophy, capsular folds and a capsular tear were present on postoperative examination.It was noted that after several crises, the disease became self-limiting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ TORIC SINGLEPIECE IOL
Type of Device
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175514979
MDR Report Key11140184
MDR Text Key225782748
Report Number1119421-2021-00052
Device Sequence Number1
Product Code MJP
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 01/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSN6AT6
Device Catalogue NumberSN6AT6.210
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/16/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-